As reported in the IRDiRC website “The members of the International Rare Disease Research Consortium’s (IRDiRC) Therapies Scientific Committee (TSC) have discussed and agreed on a specific set of recommendations to guide policies and funding strategies so as to reach its goal of 200 new therapies by 2020, based on IRDiRC Polices & Guidelines which were adopted in April 2013”. Read the complete text of the newsIRDiRC at:

http://www.irdirc.org/tsc-recommendations/